VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ZTSZoetis Inc.
$78.71$33.0B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksZTSPrice Target
ZTS logo

Zoetis Inc. (ZTS) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Hold
Based on 30 analysts

53.5% Below Target

ZTS trades 53.5% below Wall Street's consensus target of $120.80.

Current Price$78.71
Average Target$120.80
Target
Current
Low$95.00
Median$115.00
High$160.00

Analyst Target Range

Forward P/E11.4x
(Value)
PEG Ratio0.95
(Undervalued)
Implied Growth+10.4%
(Moderate)
Analyst Spread53.8%
(Moderate)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$78.71
Consensus$120.80
High$160.00
Low$95.00

Consensus Scenario Assumptions

The base valuation assumes ZTS achieves its forward estimates and maintains a stable P/E multiple of 11.4x. This scenario reflects the blended consensus of 30 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 30 published analyst recommendations for ZTS

50% hold / mixed conviction
+27
BearishBullish
Weighted analyst sentiment score based on 30 ratings
ConsensusHold
Coverage30 Analysts
Net Score+27
Bull / Bear50% / 0%
Strong Buy13%
Buy1447%
Hold1550%
Sell00%
Strong Sell00%
Strong Buy
13%
Buy
1447%
Hold
1550%
Sell
00%
Strong Sell
00%
Recommendation Mix50% Buy · 50% Hold · 0% Sell
Buy (15)Hold (15)Sell (0)

ZTS Price Target Analysis

Updated June 21, 2026

As of June 21, 2026, Zoetis Inc. (ZTS) has a Wall Street consensus price target of $120.80, based on estimates from 30 covering analysts. With the stock currently trading at $78.71, this represents a potential upside of +53.5%. The company has a market capitalization of $33.00B.

Analyst price targets range from a low of $95.00 to a high of $160.00, representing a 54% spread in expectations. The median target of $115.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.

The current analyst consensus rating is Hold, with 15 analysts rating the stock as a Buy or Strong Buy,15 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, ZTS trades at a trailing P/E of 13.1x and forward P/E of 11.4x. The forward PEG ratio of 0.95 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +10.4% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $94.01, with bear and bull scenarios of $59.23 and $123.87 respectively. Model confidence stands at 62/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+23.7%
Industry Consensus
Avg Forward P/E
18.9x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
ELAN logo
ELANElanco Animal Health Incorporated
$12.1B$24.22$28.40
+17.3%
Buy22.9x20
PCRX logo
PCRXPacira BioSciences, Inc.
$878M$22.33$32.00
+43.3%
Hold7.8x36
PAHC logo
PAHCPhibro Animal Health Corporation
$1.3B$31.85$49.00
+53.8%
Buy10.4x14
IDXX logo
IDXXIDEXX Laboratories, Inc.
$44.6B$562.09$747.50
+33.0%
Buy38.3x22
NEOG logo
NEOGNeogen Corporation
$2.0B$9.31$11.00
+18.2%
Hold25.2x11
MRK logo
MRKMerck & Co., Inc.
$281.2B$113.87$131.58
+15.6%
Buy22.2x37
PFE logo
PFEPfizer Inc.
$143.5B$25.22$26.75
+6.1%
Hold8.5x39
ABBV logo
ABBVAbbVie Inc.
$383.2B$216.63$256.92
+18.6%
Buy15.2x41
LLY logo
LLYEli Lilly and Company
$1.0T$1098.13$1271.24
+15.8%
Buy30.0x45
BMY logo
BMYBristol-Myers Squibb Company
$110.3B$54.00$62.60
+15.9%
Hold8.5x41

ZTS — Frequently Asked Questions

Quick answers to the most common questions about buying ZTS stock.

What is the ZTS stock price target for 2026?

The consensus Wall Street price target for ZTS is $120.8, representing 53.5% upside from the current price of $78.71. With 30 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is ZTS a buy, sell, or hold?

ZTS has a consensus rating of "Hold" based on 30 Wall Street analysts. The rating breakdown is mixed, with 15 Hold ratings making up the largest segment. The consensus 12-month price target of $120.8 implies 53.5% upside from current levels.

Is ZTS stock overvalued or undervalued?

With a forward P/E of 11.3935x, ZTS trades at a relatively low valuation. The consensus target of $120.8 implies 53.5% appreciation, suggesting meaningful undervaluation.

How high can ZTS stock go?

The most bullish Wall Street analyst has a price target of $160 for ZTS, while the most conservative target is $95. The consensus of $120.8 represents the median expectation. Our quantitative valuation model projects a bull case target of $124 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover ZTS stock?

ZTS is heavily covered by Wall Street, with 30 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 14 have Buy ratings, 15 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the ZTS stock forecast?

The 12-month ZTS stock forecast based on 30 Wall Street analysts shows a consensus price target of $120.8, with estimates ranging from $95 (bear case) to $160 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $94, with bear/bull scenarios of $59/$124.

What is ZTS's fair value based on fundamentals?

Our quantitative valuation model calculates ZTS's fair value at $94 (base case), with a bear case of $59 and bull case of $124. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 62/100.

What is ZTS's forward P/E ratio?

ZTS trades at a forward P/E ratio of 11.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy ZTS stock?

Wall Street analysts are very optimistic on ZTS, with a "Hold" consensus rating and $120.8 price target (53.5% upside). 15 of 30 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do ZTS price targets vary so much?

ZTS analyst price targets range from $95 to $160, a 54% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $120.8 consensus represents the middle ground. Our model's $59-$124 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into ZTS consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare